Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Halozyme Therapeutics Inc. buy TD Cowen

Start price
€89.18
07.08.26 / 50%
Target price
€91.12
07.08.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.08.27. The prediction end date can be changed by TD_Cowen at any time.
Performance without dividends (%)
Name 1w
Halozyme Therapeutics Inc. -
iShares Core DAX® 2.573%
iShares Nasdaq 100 4.858%
iShares Nikkei 225® 5.590%
iShares S&P 500 3.250%

Comments by TD_Cowen for this prediction

In the thread Halozyme Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 91.119
Change
Ends at 07.08.27

Halozyme Therapeutics (HALO) had its price target raised by TD Cowen from $96.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for HALO provided by MarketBeat

Stopped prediction by TD_Cowen for Halozyme Therapeutics Inc.

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€61.94
18.02.26
-
18.02.27
43.98%
07.08.26

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€62.16
08.01.26
€77.09
08.01.27
43.47%
07.08.26